Marshall Wace’s Humanigen HGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding HGEN
TI
Marshall Wace's HGEN Position: Q3 2022 in Review
Marshall Wace sold out of Humanigen (HGEN) in Q3 2022, closing a stake of 608,736 shares — an estimated $1.08M sold.
Marshall Wace first reported a position in HGEN in Q1 2021 and held it in 5 quarters. The position peaked at $9.17M in Q1 2021. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.
- Marshall Wace reported no remaining Humanigen position as of Q3 2022 after selling out during the quarter.
- Marshall Wace sold 608,736 Humanigen shares in Q3 2022, an estimated $1.08M.
- Marshall Wace first reported a position in Humanigen in Q1 2021 and held it in 5 quarters.
- Marshall Wace's Humanigen position peaked at $9.17M in Q1 2021.
- 53 funds tracked by Wall St. Rank held Humanigen as of Q3 2022.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.